JP2012517470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012517470A5 JP2012517470A5 JP2011550122A JP2011550122A JP2012517470A5 JP 2012517470 A5 JP2012517470 A5 JP 2012517470A5 JP 2011550122 A JP2011550122 A JP 2011550122A JP 2011550122 A JP2011550122 A JP 2011550122A JP 2012517470 A5 JP2012517470 A5 JP 2012517470A5
- Authority
- JP
- Japan
- Prior art keywords
- quinazoline
- carboxylic acid
- phenyl
- acid amide
- ethylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 methoxy, ethoxy Chemical group 0.000 claims 38
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 26
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 12
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- 239000012453 solvate Substances 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 7
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 claims 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims 5
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 2
- UFMCGKYLIYMLOY-CQSZACIVSA-N 4-[[(1s)-2-amino-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)CN)=CC=CC=C1 UFMCGKYLIYMLOY-CQSZACIVSA-N 0.000 claims 2
- UALHJBCHHRMERK-UHFFFAOYSA-N 4-[[2-amino-1-(3,4-dichlorophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN)C1=CC=C(Cl)C(Cl)=C1 UALHJBCHHRMERK-UHFFFAOYSA-N 0.000 claims 2
- SGZFLJKVODZGJM-UHFFFAOYSA-N 4-[[2-amino-1-(3,4-dimethoxyphenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C(CN)NC1=NC=NC2=C(C(N)=O)C=CC=C12 SGZFLJKVODZGJM-UHFFFAOYSA-N 0.000 claims 2
- IKONXWFEIGCAGN-UHFFFAOYSA-N 4-[[2-amino-1-(3-fluorophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN)C1=CC=CC(F)=C1 IKONXWFEIGCAGN-UHFFFAOYSA-N 0.000 claims 2
- PRHCRPUDJXUXCO-UHFFFAOYSA-N 4-[[2-amino-1-(4-methoxyphenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=CC(OC)=CC=C1C(CN)NC1=NC=NC2=C(C(N)=O)C=CC=C12 PRHCRPUDJXUXCO-UHFFFAOYSA-N 0.000 claims 2
- QVHGKNYBLQTWEC-UHFFFAOYSA-N 4-[[2-amino-1-(4-methylphenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=CC(C)=CC=C1C(CN)NC1=NC=NC2=C(C(N)=O)C=CC=C12 QVHGKNYBLQTWEC-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 1
- XMZNZUXMEXIQDA-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC1=CC=C(Cl)C(Cl)=C1 XMZNZUXMEXIQDA-UHFFFAOYSA-N 0.000 claims 1
- CKSGWNWLYXUENQ-UHFFFAOYSA-N 4-[(3,4-dimethylphenyl)methylamino]quinazoline-8-carboxamide Chemical compound C1=C(C)C(C)=CC=C1CNC1=NC=NC2=C(C(N)=O)C=CC=C12 CKSGWNWLYXUENQ-UHFFFAOYSA-N 0.000 claims 1
- YNPQIFHMRSVLHW-UHFFFAOYSA-N 4-[1-[3-(1,3-benzodioxole-5-carbonylamino)phenyl]ethylamino]quinazoline-8-carboxamide Chemical compound C1=C2OCOC2=CC(C(=O)NC=2C=CC=C(C=2)C(NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=C1 YNPQIFHMRSVLHW-UHFFFAOYSA-N 0.000 claims 1
- BZNBBOLMYRXASK-UHFFFAOYSA-N 4-[1-[3-[(3-fluoro-4-methylbenzoyl)amino]phenyl]ethylamino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(C)C(F)=C1 BZNBBOLMYRXASK-UHFFFAOYSA-N 0.000 claims 1
- QBWMPYZCKOEWSU-UHFFFAOYSA-N 4-[1-[3-[(4-bromobenzoyl)amino]phenyl]ethylamino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(Br)C=C1 QBWMPYZCKOEWSU-UHFFFAOYSA-N 0.000 claims 1
- SICPNVSSMIOAEC-UHFFFAOYSA-N 4-[1-[3-[(4-fluoro-3-hydroxybenzoyl)amino]phenyl]ethylamino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C(O)=C1 SICPNVSSMIOAEC-UHFFFAOYSA-N 0.000 claims 1
- SRJJNRIRROSSLD-UHFFFAOYSA-N 4-[1-[3-[(5-tert-butyl-1h-pyrazole-3-carbonyl)amino]phenyl]ethylamino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(C)C(C=1)=CC=CC=1NC(=O)C1=CC(C(C)(C)C)=NN1 SRJJNRIRROSSLD-UHFFFAOYSA-N 0.000 claims 1
- POBKWGYBFDTZBY-UHFFFAOYSA-N 4-[1-[3-[(6-methoxypyridine-3-carbonyl)amino]phenyl]propylamino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(OC)N=C1 POBKWGYBFDTZBY-UHFFFAOYSA-N 0.000 claims 1
- KQPMGHOTWSCTSB-UHFFFAOYSA-N 4-[2-(1h-indol-3-yl)ethylamino]quinazoline-8-carboxamide Chemical compound C1=CC=C2C(CCNC3=C4C=CC=C(C4=NC=N3)C(=O)N)=CNC2=C1 KQPMGHOTWSCTSB-UHFFFAOYSA-N 0.000 claims 1
- YNPQIFHMRSVLHW-CQSZACIVSA-N 4-[[(1r)-1-[3-(1,3-benzodioxole-5-carbonylamino)phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=C2OCOC2=CC(C(=O)NC=2C=CC=C(C=2)[C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=C1 YNPQIFHMRSVLHW-CQSZACIVSA-N 0.000 claims 1
- VQTZMSIOEYJERT-ZVDHGWRTSA-N 4-[[(1r)-1-[3-[(2,2-difluorocyclopropanecarbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1CC1(F)F VQTZMSIOEYJERT-ZVDHGWRTSA-N 0.000 claims 1
- NXUJCUODKLXIPE-CQSZACIVSA-N 4-[[(1r)-1-[3-[(2-methoxypyridine-4-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=NC(OC)=CC(C(=O)NC=2C=C(C=CC=2)[C@@H](C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 NXUJCUODKLXIPE-CQSZACIVSA-N 0.000 claims 1
- KWBXLLQBOZJIAV-QGZVFWFLSA-N 4-[[(1r)-1-[3-[(3,4-dimethylbenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC=C(C)C(C)=C1 KWBXLLQBOZJIAV-QGZVFWFLSA-N 0.000 claims 1
- CVCLGNCOASWGPB-OAHLLOKOSA-N 4-[[(1r)-1-[3-[(4-chloro-3-methylbenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC=C(Cl)C(C)=C1 CVCLGNCOASWGPB-OAHLLOKOSA-N 0.000 claims 1
- ZSTHXAKLQBVNDX-CQSZACIVSA-N 4-[[(1r)-1-[3-[(5,6-dimethoxypyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N1=C(OC)C(OC)=CC(C(=O)NC=2C=C(C=CC=2)[C@@H](C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 ZSTHXAKLQBVNDX-CQSZACIVSA-N 0.000 claims 1
- SHFIJZVQMKWQNN-CYBMUJFWSA-N 4-[[(1r)-1-[3-[(5-chloro-6-methoxypyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=C(Cl)C(OC)=NC=C1C(=O)NC1=CC=CC([C@@H](C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 SHFIJZVQMKWQNN-CYBMUJFWSA-N 0.000 claims 1
- TUVCZMWCKOCSGF-CQSZACIVSA-N 4-[[(1r)-1-[3-[(5-propan-2-yl-1h-pyrazole-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N1C(C(C)C)=CC(C(=O)NC=2C=C(C=CC=2)[C@@H](C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=N1 TUVCZMWCKOCSGF-CQSZACIVSA-N 0.000 claims 1
- SRJJNRIRROSSLD-CQSZACIVSA-N 4-[[(1r)-1-[3-[(5-tert-butyl-1h-pyrazole-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC(C(C)(C)C)=NN1 SRJJNRIRROSSLD-CQSZACIVSA-N 0.000 claims 1
- GLMIBJBCEWSYSZ-CQSZACIVSA-N 4-[[(1r)-1-[3-[(6-cyanopyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC=C(C#N)N=C1 GLMIBJBCEWSYSZ-CQSZACIVSA-N 0.000 claims 1
- GTUAZZUFAUMXII-CQSZACIVSA-N 4-[[(1r)-1-[3-[(6-methoxypyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=NC(OC)=CC=C1C(=O)NC1=CC=CC([C@@H](C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 GTUAZZUFAUMXII-CQSZACIVSA-N 0.000 claims 1
- JMHMGIHHTONCMK-OAHLLOKOSA-N 4-[[(1r)-1-[3-[(6-methylpyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC=C(C)N=C1 JMHMGIHHTONCMK-OAHLLOKOSA-N 0.000 claims 1
- RWBMPHFTXFAKIZ-CYBMUJFWSA-N 4-[[(1r)-1-[3-[[2-fluoro-4-(trifluoromethyl)benzoyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC=C(C(F)(F)F)C=C1F RWBMPHFTXFAKIZ-CYBMUJFWSA-N 0.000 claims 1
- PELODSQJHQJMMD-CYBMUJFWSA-N 4-[[(1r)-1-[3-[[2-fluoro-5-(trifluoromethyl)benzoyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)C)=CC=CC=1NC(=O)C1=CC(C(F)(F)F)=CC=C1F PELODSQJHQJMMD-CYBMUJFWSA-N 0.000 claims 1
- KFUGVCOVSKGHMS-HNNXBMFYSA-N 4-[[(1r)-2-(methylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC=C1 KFUGVCOVSKGHMS-HNNXBMFYSA-N 0.000 claims 1
- KTEVQEUEMLYYMP-MRXNPFEDSA-N 4-[[(1s)-1-(3-chlorophenyl)-2-(methylamino)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC(OC)=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC(Cl)=C1 KTEVQEUEMLYYMP-MRXNPFEDSA-N 0.000 claims 1
- XQZHZCUJORPEOS-MRXNPFEDSA-N 4-[[(1s)-1-(3-fluorophenyl)-2-(methylamino)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC(OC)=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC(F)=C1 XQZHZCUJORPEOS-MRXNPFEDSA-N 0.000 claims 1
- RBMOLIOJAWRTIV-OAHLLOKOSA-N 4-[[(1s)-1-(3-fluorophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC(F)=C1 RBMOLIOJAWRTIV-OAHLLOKOSA-N 0.000 claims 1
- BFLHCYRERXMTKZ-QGZVFWFLSA-N 4-[[(1s)-2-(dimethylamino)-1-(3-fluorophenyl)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C1([C@@H](CN(C)C)NC2=NC=NC3=C(C(N)=O)C=C(C=C32)OC)=CC=CC(F)=C1 BFLHCYRERXMTKZ-QGZVFWFLSA-N 0.000 claims 1
- GEECDZLHNUPFCU-MRXNPFEDSA-N 4-[[(1s)-2-(ethylamino)-1-(3-fluorophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)CNCC)=CC=CC(F)=C1 GEECDZLHNUPFCU-MRXNPFEDSA-N 0.000 claims 1
- XAVPWAIYBBCDNE-QGZVFWFLSA-N 4-[[(1s)-2-(ethylamino)-1-phenylethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC(OC)=CC(=C3N=CN=2)C(N)=O)CNCC)=CC=CC=C1 XAVPWAIYBBCDNE-QGZVFWFLSA-N 0.000 claims 1
- HITVHYHCWXALKZ-MRXNPFEDSA-N 4-[[(1s)-2-(ethylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)CNCC)=CC=CC=C1 HITVHYHCWXALKZ-MRXNPFEDSA-N 0.000 claims 1
- HNAFGFOVDGEYQN-OAHLLOKOSA-N 4-[[(1s)-2-amino-1-phenylethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C1([C@@H](CN)NC2=NC=NC3=C(C(N)=O)C=C(C=C32)OC)=CC=CC=C1 HNAFGFOVDGEYQN-OAHLLOKOSA-N 0.000 claims 1
- CHKCVVJJVFZWOP-KXCGHJCSSA-N 4-[[(3r,4e)-1-amino-4-ethenylhepta-4,6-dien-3-yl]amino]quinazoline-8-carboxamide Chemical compound C1=CC=C2C(N[C@H](CCN)C(\C=C)=C\C=C)=NC=NC2=C1C(N)=O CHKCVVJJVFZWOP-KXCGHJCSSA-N 0.000 claims 1
- AGDQZNITYJKXQO-UHFFFAOYSA-N 4-[[1-(3,4-dichlorophenyl)-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C1=CC=C(Cl)C(Cl)=C1 AGDQZNITYJKXQO-UHFFFAOYSA-N 0.000 claims 1
- BYUUFRNHCFTPTI-UHFFFAOYSA-N 4-[[1-(3,4-dichlorophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C1=CC=C(Cl)C(Cl)=C1 BYUUFRNHCFTPTI-UHFFFAOYSA-N 0.000 claims 1
- HZCSYARAUKXOFF-UHFFFAOYSA-N 4-[[1-(3-benzamidophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=CC=C1 HZCSYARAUKXOFF-UHFFFAOYSA-N 0.000 claims 1
- QZMSENZZQWAYFQ-UHFFFAOYSA-N 4-[[1-(3-bromophenyl)-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C1=CC=CC(Br)=C1 QZMSENZZQWAYFQ-UHFFFAOYSA-N 0.000 claims 1
- ODIBHBBABRKJIO-UHFFFAOYSA-N 4-[[1-(3-chlorophenyl)-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C1=CC=CC(Cl)=C1 ODIBHBBABRKJIO-UHFFFAOYSA-N 0.000 claims 1
- KTEVQEUEMLYYMP-UHFFFAOYSA-N 4-[[1-(3-chlorophenyl)-2-(methylamino)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=C(OC)C=C2C=1NC(CNC)C1=CC=CC(Cl)=C1 KTEVQEUEMLYYMP-UHFFFAOYSA-N 0.000 claims 1
- OPYPJZSJHHSMJL-UHFFFAOYSA-N 4-[[1-(3-chlorophenyl)-2-(methylamino)ethyl]amino]-6-phenylmethoxyquinazoline-8-carboxamide Chemical compound C=1C=CC(Cl)=CC=1C(CNC)NC(C1=C2)=NC=NC1=C(C(N)=O)C=C2OCC1=CC=CC=C1 OPYPJZSJHHSMJL-UHFFFAOYSA-N 0.000 claims 1
- LAJUPICIRDRINN-UHFFFAOYSA-N 4-[[1-(3-chlorophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C1=CC=CC(Cl)=C1 LAJUPICIRDRINN-UHFFFAOYSA-N 0.000 claims 1
- XQZHZCUJORPEOS-UHFFFAOYSA-N 4-[[1-(3-fluorophenyl)-2-(methylamino)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=C(OC)C=C2C=1NC(CNC)C1=CC=CC(F)=C1 XQZHZCUJORPEOS-UHFFFAOYSA-N 0.000 claims 1
- RBMOLIOJAWRTIV-UHFFFAOYSA-N 4-[[1-(3-fluorophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C1=CC=CC(F)=C1 RBMOLIOJAWRTIV-UHFFFAOYSA-N 0.000 claims 1
- CJAKBHSFDAWLEM-UHFFFAOYSA-N 4-[[1-(4-chlorophenyl)-2-(dimethylamino)ethyl]amino]-6-methoxyquinazoline-8-carboxamide Chemical compound C12=CC(OC)=CC(C(N)=O)=C2N=CN=C1NC(CN(C)C)C1=CC=C(Cl)C=C1 CJAKBHSFDAWLEM-UHFFFAOYSA-N 0.000 claims 1
- ZJKRQNYRWHKMJV-UHFFFAOYSA-N 4-[[1-(4-methoxyphenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C1=CC=C(OC)C=C1 ZJKRQNYRWHKMJV-UHFFFAOYSA-N 0.000 claims 1
- MFRRIEBIBJQMAF-UHFFFAOYSA-N 4-[[1-[3-[(2,4-difluorobenzoyl)amino]phenyl]-3-(dimethylamino)propyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CCN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C=C1F MFRRIEBIBJQMAF-UHFFFAOYSA-N 0.000 claims 1
- NOOJGWFQMPPHRX-UHFFFAOYSA-N 4-[[1-[3-[(2,4-difluorobenzoyl)amino]phenyl]-3-methoxypropyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CCOC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C=C1F NOOJGWFQMPPHRX-UHFFFAOYSA-N 0.000 claims 1
- JKUFJTIKVQADGJ-UHFFFAOYSA-N 4-[[1-[3-[(2,6-difluorobenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=C(F)C=CC=C1F JKUFJTIKVQADGJ-UHFFFAOYSA-N 0.000 claims 1
- FFJNCCISXWZBSC-UHFFFAOYSA-N 4-[[1-[3-[(2,6-difluorobenzoyl)amino]phenyl]-3-methoxypropyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CCOC)C(C=1)=CC=CC=1NC(=O)C1=C(F)C=CC=C1F FFJNCCISXWZBSC-UHFFFAOYSA-N 0.000 claims 1
- NERGHRXOVVUXNP-UHFFFAOYSA-N 4-[[1-[3-[(2-chloropyridine-4-carbonyl)amino]phenyl]-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=NC(Cl)=C1 NERGHRXOVVUXNP-UHFFFAOYSA-N 0.000 claims 1
- GYEINYAKLFRDRF-UHFFFAOYSA-N 4-[[1-[3-[(2-fluoro-4-methoxybenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(OC)C=C1F GYEINYAKLFRDRF-UHFFFAOYSA-N 0.000 claims 1
- FIZSPRJMYGKSMB-UHFFFAOYSA-N 4-[[1-[3-[(3,4-difluorobenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C(F)=C1 FIZSPRJMYGKSMB-UHFFFAOYSA-N 0.000 claims 1
- UUQUQPUHXKTHDD-UHFFFAOYSA-N 4-[[1-[3-[(3-fluoro-4-methoxybenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(OC)C(F)=C1 UUQUQPUHXKTHDD-UHFFFAOYSA-N 0.000 claims 1
- YRQSEFHVBKRZFV-UHFFFAOYSA-N 4-[[1-[3-[(4-bromobenzoyl)amino]phenyl]-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(Br)C=C1 YRQSEFHVBKRZFV-UHFFFAOYSA-N 0.000 claims 1
- RHWHWWRJINHZQN-UHFFFAOYSA-N 4-[[1-[3-[(4-bromobenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(Br)C=C1 RHWHWWRJINHZQN-UHFFFAOYSA-N 0.000 claims 1
- YGQJBWJOHRVWHU-UHFFFAOYSA-N 4-[[1-[3-[(4-bromobenzoyl)amino]phenyl]-3-(dimethylamino)propyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CCN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(Br)C=C1 YGQJBWJOHRVWHU-UHFFFAOYSA-N 0.000 claims 1
- CNFJGGPOIJUVKL-UHFFFAOYSA-N 4-[[1-[3-[(4-methoxybenzoyl)amino]phenyl]-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(OC)C=C1 CNFJGGPOIJUVKL-UHFFFAOYSA-N 0.000 claims 1
- JHGDIFKUZFGJGH-UHFFFAOYSA-N 4-[[1-[3-[[2-[3-(diethylamino)pyrrolidin-1-yl]pyridine-4-carbonyl]amino]phenyl]-2-(dimethylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1C(N(CC)CC)CCN1C1=CC(C(=O)NC=2C=C(C=CC=2)C(CN(C)C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=CC=N1 JHGDIFKUZFGJGH-UHFFFAOYSA-N 0.000 claims 1
- ALLGNFRRMBCRHD-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-(3-methoxyphenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound COC1=CC=CC(C(CN(C)C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 ALLGNFRRMBCRHD-UHFFFAOYSA-N 0.000 claims 1
- PPACVGVOVMKIML-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-(3-nitrophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C1=CC=CC([N+]([O-])=O)=C1 PPACVGVOVMKIML-UHFFFAOYSA-N 0.000 claims 1
- HAWOAWLBNXPWTR-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(2-fluorobenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=CC=C1F HAWOAWLBNXPWTR-UHFFFAOYSA-N 0.000 claims 1
- POQNJRCZSQACTE-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(2-piperidin-1-ylpyridine-4-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C(C=1)=CC=NC=1N1CCCCC1 POQNJRCZSQACTE-UHFFFAOYSA-N 0.000 claims 1
- VWYGEDAFWDXUMQ-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(2-pyrrolidin-1-ylpyridine-4-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C(C=1)=CC=NC=1N1CCCC1 VWYGEDAFWDXUMQ-UHFFFAOYSA-N 0.000 claims 1
- LYOMZOFITVVBNX-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(3-fluoro-4-methoxybenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1C(=O)NC1=CC=CC(C(CN(C)C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 LYOMZOFITVVBNX-UHFFFAOYSA-N 0.000 claims 1
- IUEUJHZZCUYXKU-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(4-methoxybenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=CC=CC(C(CN(C)C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 IUEUJHZZCUYXKU-UHFFFAOYSA-N 0.000 claims 1
- DCRRXSUQGXVDLQ-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[(5-pyrrolidin-1-ylpyridine-3-carbonyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C(C=1)=CN=CC=1N1CCCC1 DCRRXSUQGXVDLQ-UHFFFAOYSA-N 0.000 claims 1
- IVOSBLQIUULOJZ-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[[2-(2-methylpyrrolidin-1-yl)pyridine-4-carbonyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound CC1CCCN1C1=CC(C(=O)NC=2C=C(C=CC=2)C(CN(C)C)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=CC=N1 IVOSBLQIUULOJZ-UHFFFAOYSA-N 0.000 claims 1
- YFTUDCDZHZYZAB-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[[2-(dimethylamino)pyridine-4-carbonyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=NC(N(C)C)=C1 YFTUDCDZHZYZAB-UHFFFAOYSA-N 0.000 claims 1
- RXAZPQCDGXHCAO-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(C(F)(F)F)C=C1 RXAZPQCDGXHCAO-UHFFFAOYSA-N 0.000 claims 1
- ZJDZJPZEQDNRHD-UHFFFAOYSA-N 4-[[2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C)C1=CC=C(C(F)(F)F)C=C1 ZJDZJPZEQDNRHD-UHFFFAOYSA-N 0.000 claims 1
- ZHHSRQFICBOYCE-UHFFFAOYSA-N 4-[[2-(methylamino)-1-[3-[[4-(trifluoromethoxy)benzoyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(OC(F)(F)F)C=C1 ZHHSRQFICBOYCE-UHFFFAOYSA-N 0.000 claims 1
- JNZCFUTUPRDOSS-UHFFFAOYSA-N 4-[[2-(methylamino)-1-[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C(C=1)=CC=CC=1NC(=O)C1=CC=C(C(F)(F)F)C=C1 JNZCFUTUPRDOSS-UHFFFAOYSA-N 0.000 claims 1
- KFUGVCOVSKGHMS-UHFFFAOYSA-N 4-[[2-(methylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CNC)C1=CC=CC=C1 KFUGVCOVSKGHMS-UHFFFAOYSA-N 0.000 claims 1
- VXICAQQGSOIIMS-UHFFFAOYSA-N 4-[[2-amino-1-(3-chlorophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN)C1=CC=CC(Cl)=C1 VXICAQQGSOIIMS-UHFFFAOYSA-N 0.000 claims 1
- YCUXZFDOLJQXOU-UHFFFAOYSA-N 4-[[2-amino-1-(3-methoxyphenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound COC1=CC=CC(C(CN)NC=2C3=CC=CC(=C3N=CN=2)C(N)=O)=C1 YCUXZFDOLJQXOU-UHFFFAOYSA-N 0.000 claims 1
- UUKGDBLVFLHJLM-UHFFFAOYSA-N 4-[[2-amino-1-[3-[(4-fluorobenzoyl)amino]phenyl]ethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN)C(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C=C1 UUKGDBLVFLHJLM-UHFFFAOYSA-N 0.000 claims 1
- BMYPGRZADREWCU-UHFFFAOYSA-N 4-[[3-(dimethylamino)-1-[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]propyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CCN(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=C(C(F)(F)F)C=C1 BMYPGRZADREWCU-UHFFFAOYSA-N 0.000 claims 1
- LJMKRAKDJVPMIO-UHFFFAOYSA-N 4-[[3-[(2,4-dichlorobenzoyl)amino]phenyl]methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC(C=1)=CC=CC=1NC(=O)C1=CC=C(Cl)C=C1Cl LJMKRAKDJVPMIO-UHFFFAOYSA-N 0.000 claims 1
- DHNWCWGJFSTRBB-UHFFFAOYSA-N 4-[[3-[(2,4-difluorobenzoyl)amino]phenyl]methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC(C=1)=CC=CC=1NC(=O)C1=CC=C(F)C=C1F DHNWCWGJFSTRBB-UHFFFAOYSA-N 0.000 claims 1
- SKTCDUXPKLCJIP-UHFFFAOYSA-N 4-[[3-[(5-pyrrolidin-1-ylpyridine-3-carbonyl)amino]phenyl]methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC(C=1)=CC=CC=1NC(=O)C(C=1)=CN=CC=1N1CCCC1 SKTCDUXPKLCJIP-UHFFFAOYSA-N 0.000 claims 1
- FTLGJGCPUAMLIH-UHFFFAOYSA-N 4-[[3-[[2-[2-hydroxyethyl(methyl)amino]pyridine-4-carbonyl]amino]phenyl]methylamino]quinazoline-8-carboxamide Chemical compound C1=NC(N(CCO)C)=CC(C(=O)NC=2C=C(CNC=3C4=CC=CC(=C4N=CN=3)C(N)=O)C=CC=2)=C1 FTLGJGCPUAMLIH-UHFFFAOYSA-N 0.000 claims 1
- YZSOMODRJHNWOR-UHFFFAOYSA-N 4-[[4-(trifluoromethyl)phenyl]methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC1=CC=C(C(F)(F)F)C=C1 YZSOMODRJHNWOR-UHFFFAOYSA-N 0.000 claims 1
- BXSXPCFESWIUHR-UHFFFAOYSA-N 4-[[4-chloro-3-(trifluoromethyl)phenyl]methylamino]quinazoline-8-carboxamide Chemical compound N1=CN=C2C(C(=O)N)=CC=CC2=C1NCC1=CC=C(Cl)C(C(F)(F)F)=C1 BXSXPCFESWIUHR-UHFFFAOYSA-N 0.000 claims 1
- GXYOPEGHNADCQI-UHFFFAOYSA-N 5-methoxy-4-[[2-(methylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=CC(OC)=C2C=1NC(CNC)C1=CC=CC=C1 GXYOPEGHNADCQI-UHFFFAOYSA-N 0.000 claims 1
- MDBLXTCBPCQULU-UHFFFAOYSA-N 6-(cyclopropylmethoxy)-4-[[2-(dimethylamino)-1-(3-fluorophenyl)ethyl]amino]quinazoline-8-carboxamide Chemical compound C=1C=CC(F)=CC=1C(CN(C)C)NC(C1=C2)=NC=NC1=C(C(N)=O)C=C2OCC1CC1 MDBLXTCBPCQULU-UHFFFAOYSA-N 0.000 claims 1
- NKFAPWMJVXBXHU-OAHLLOKOSA-N 6-chloro-4-[[(1s)-1-(3-fluorophenyl)-2-(methylamino)ethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC(Cl)=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC(F)=C1 NKFAPWMJVXBXHU-OAHLLOKOSA-N 0.000 claims 1
- UVOCNINDPZNPIC-MRXNPFEDSA-N 6-methoxy-4-[[(1s)-2-(methylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound C1([C@H](NC=2C3=CC(OC)=CC(=C3N=CN=2)C(N)=O)CNC)=CC=CC=C1 UVOCNINDPZNPIC-MRXNPFEDSA-N 0.000 claims 1
- UVOCNINDPZNPIC-UHFFFAOYSA-N 6-methoxy-4-[[2-(methylamino)-1-phenylethyl]amino]quinazoline-8-carboxamide Chemical compound N=1C=NC2=C(C(N)=O)C=C(OC)C=C2C=1NC(CNC)C1=CC=CC=C1 UVOCNINDPZNPIC-UHFFFAOYSA-N 0.000 claims 1
- FTCVWEWECUNCTD-UHFFFAOYSA-N 6-methoxy-4-[[4-(trifluoromethyl)phenyl]methylamino]quinazoline-8-carboxamide Chemical compound C12=CC(OC)=CC(C(N)=O)=C2N=CN=C1NCC1=CC=C(C(F)(F)F)C=C1 FTCVWEWECUNCTD-UHFFFAOYSA-N 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 125000000815 N-oxide group Chemical group 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical group C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- GTCAXTIRRLKXRU-UHFFFAOYSA-N carbamic acid methyl ester Natural products COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 229940125877 compound 31 Drugs 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 201000011066 hemangioma Diseases 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 230000003463 hyperproliferative effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- DLYKSKLOFRPDPD-UHFFFAOYSA-N tert-butyl n-[2-(3-benzamidophenyl)-2-[(8-carbamoylquinazolin-4-yl)amino]ethyl]-n-methylcarbamate Chemical compound N=1C=NC2=C(C(N)=O)C=CC=C2C=1NC(CN(C)C(=O)OC(C)(C)C)C(C=1)=CC=CC=1NC(=O)C1=CC=CC=C1 DLYKSKLOFRPDPD-UHFFFAOYSA-N 0.000 claims 1
- 230000005747 tumor angiogenesis Effects 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20735409P | 2009-02-11 | 2009-02-11 | |
| US61/207,354 | 2009-02-11 | ||
| PCT/US2010/000313 WO2010093419A1 (en) | 2009-02-11 | 2010-02-04 | Novel amino azaheterocyclic carboxamides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012517470A JP2012517470A (ja) | 2012-08-02 |
| JP2012517470A5 true JP2012517470A5 (cg-RX-API-DMAC10.html) | 2013-03-28 |
| JP5642714B2 JP5642714B2 (ja) | 2014-12-17 |
Family
ID=42199208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011550122A Active JP5642714B2 (ja) | 2009-02-11 | 2010-02-04 | 新規なアミノアザヘテロ環式カルボキサミド |
Country Status (25)
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA110113C2 (xx) | 2010-07-29 | 2015-11-25 | Біциклічні азагетероциклічні карбоксаміди | |
| US9586938B2 (en) * | 2010-07-29 | 2017-03-07 | Merck Patent Gmbh | Cyclic amine azaheterocyclic carboxamides |
| EA023821B1 (ru) * | 2010-11-24 | 2016-07-29 | Мерк Патент Гмбх | Хиназолинкарбоксамидазетидины, их применение в лечении гиперпролиферативных заболеваний и содержащие их композиции |
| ES2646759T3 (es) | 2011-09-12 | 2017-12-15 | Merck Patent Gmbh | Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa |
| HRP20171554T1 (hr) | 2011-09-12 | 2017-11-17 | Merck Patent Gmbh | Novi imidazol amini kao modulatori aktivnosti kinaze |
| WO2013096194A1 (en) * | 2011-12-22 | 2013-06-27 | Merck Patent Gmbh | Novel heterocyclic carboxamides as modulators of kinase activity |
| AR093511A1 (es) | 2012-11-16 | 2015-06-10 | Merck Patent Gmbh | Derivados de imidazol-piperidinilo como moduladores de la actividad de cinasas |
| AR093512A1 (es) | 2012-11-16 | 2015-06-10 | Merck Patent Gmbh | Derivados heterociclicos como moduladores de la actividad de cinasas |
| EA033655B1 (ru) * | 2012-11-29 | 2019-11-13 | Merck Patent Gmbh | Производные азахиназолин карбоксамида |
| BR122021012629B1 (pt) | 2013-02-01 | 2022-06-07 | Wellstat Therapeutics Corporation | Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos |
| MX370448B (es) | 2013-03-11 | 2019-12-13 | Merck Patent Gmbh | Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa. |
| GB201317609D0 (en) | 2013-10-04 | 2013-11-20 | Cancer Rec Tech Ltd | Inhibitor compounds |
| NZ725361A (en) | 2014-04-03 | 2022-09-30 | Merck Patent Gmbh | Combinations of cancer therapeutics |
| CN104292170B (zh) * | 2014-09-22 | 2016-06-29 | 广西师范大学 | 具有抗肿瘤作用的喹唑啉-芳基脲衍生物及其应用 |
| WO2016064970A1 (en) * | 2014-10-22 | 2016-04-28 | The Board Of Regents Of The University Of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
| GB201505658D0 (en) | 2015-04-01 | 2015-05-13 | Cancer Rec Tech Ltd | Inhibitor compounds |
| GB201617103D0 (en) | 2016-10-07 | 2016-11-23 | Cancer Research Technology Limited | Compound |
| FR3066761B1 (fr) * | 2017-05-23 | 2020-10-30 | Centre Nat Rech Scient | Nouveaux composes inhibiteurs des canaux ioniques |
| WO2019006322A1 (en) * | 2017-06-30 | 2019-01-03 | The University Of North Carolina At Chapel Hill | HETEROCROMATINE GENE REPRESSION INHIBITORS |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| TWI853814B (zh) * | 2018-05-31 | 2024-09-01 | 南韓商Ｃ＆Ｃ新藥研究所 | 雜環衍生物及其用途 |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| CN109369634B (zh) * | 2018-12-19 | 2021-07-27 | 陕西国际商贸学院 | 具有抗肿瘤活性的2-甲氧基烟酰胺衍生物制备方法及用途 |
| RU2723481C1 (ru) * | 2019-10-03 | 2020-06-11 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УНИТАРНОЕ ПРЕДПРИЯТИЕ "ИНСТИТУТ ХИМИЧЕСКИХ РЕАКТИВОВ И ОСОБО ЧИСТЫХ ХИМИЧЕСКИХ ВЕЩЕСТВ НАЦИОНАЛЬНОГО ИССЛЕДОВАТЕЛЬСКОГО ЦЕНТРА "КУРЧАТОВСКИЙ ИНСТИТУТ" (НИЦ "Курчатовский институт - ИРЕА) | 4-[метил 4-(аминометил)циклогексанкарбоксилат]хиназолин и способ его получения |
| ES3055187T3 (en) | 2019-11-01 | 2026-02-10 | Syngenta Crop Protection Ag | Pesticidally active fused bicyclic heteroaromatic compounds |
| CN112778217B (zh) * | 2019-11-08 | 2024-01-26 | 沈阳化工研究院有限公司 | 一种喹唑啉类化合物及其应用 |
| IL302951A (en) | 2020-11-16 | 2023-07-01 | Merck Patent Gmbh | Kinase inhibitor combinations for cancer treatment |
| BR112023011284A2 (pt) | 2020-12-09 | 2024-02-06 | Wellstat Therapeutics Corp | Composto de imidazoquinolina com atividade anti-inflamatória, antifúngica, antiparasítica e antineoplásica |
| JP2024524851A (ja) * | 2021-06-11 | 2024-07-09 | 大塚製薬株式会社 | Ｅｒｋ阻害剤を調製するプロセス |
| KR20240024926A (ko) | 2021-06-24 | 2024-02-26 | 신젠타 크롭 프로텍션 아게 | 살충제로서의 2-[3-[1[(퀴나졸린-4-일)아미노]에틸]피라진-2-일]티아졸-5-카르보니트릴 유도체 및 유사한 화합물 |
| TW202345806A (zh) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | 噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑 |
| US20250320228A1 (en) * | 2022-04-11 | 2025-10-16 | Merck Patent Gmbh | Pyrido[3,2-d]pyrimidines as hpk1 inhibitors |
| EP4543873A1 (en) | 2022-06-21 | 2025-04-30 | Syngenta Crop Protection AG | Pesticidally active fused bicyclic heteroaromatic compounds |
| CN115521474B (zh) * | 2022-09-30 | 2023-08-22 | 陕西科技大学 | 一种基于五重互穿氢键有机框架材料及其制备方法和应用 |
| WO2025228828A1 (en) * | 2024-04-29 | 2025-11-06 | Merck Patent Gmbh | Carboxamide compounds for the treatment and prevention of viral diseases |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5651457A (en) * | 1979-09-14 | 1981-05-09 | Dev Finance | Antitumoral compound and its manufacture |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| AR016817A1 (es) * | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
| EE200200119A (et) * | 1999-09-21 | 2003-04-15 | Astrazeneca Ab | Kinasoliini derivaadid ja nende kasutamine ravimitena |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| AU5261001A (en) * | 2000-04-27 | 2001-11-12 | Imperial Cancer Research Technology Ltd | Condensed heteroaryl derivatives |
| BR0111754A (pt) * | 2000-06-28 | 2003-04-29 | Astrazeneca Ab | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica |
| ATE446093T1 (de) * | 2001-12-24 | 2009-11-15 | Astrazeneca Ab | Substituierte chinazolin-derivate als aurora- kinase inhibitoren |
| TW200306819A (en) | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
| US7547794B2 (en) | 2003-04-03 | 2009-06-16 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
| US7189729B2 (en) | 2003-09-30 | 2007-03-13 | Irm Llc | Methods and compositions as protein kinase inhibitors |
| US7816353B2 (en) | 2003-10-24 | 2010-10-19 | Exelixis, Inc. | P70S6 kinase modulators and method of use |
| RU2006121646A (ru) | 2003-11-21 | 2008-01-10 | Новартис АГ (CH) | Производные 1h-имидазохинолина в качестве ингибиторов протеинкиназы |
| BRPI0417498A (pt) | 2003-12-09 | 2007-05-29 | Us Gov Health & Human Serv | método para suprimir uma resposta imune em um indivìduo; método de inibição da proliferação de um célula; método de tratamento de um distúrbio proliferativo em um indivìduo; método para selecionar um agente imunossupressor ou anti-proliferativo; composição farmacêutica e estente vascular |
| WO2005117909A2 (en) | 2004-04-23 | 2005-12-15 | Exelixis, Inc. | Kinase modulators and methods of use |
| AU2005322085B2 (en) | 2004-12-28 | 2012-07-19 | Exelixis, Inc. | [1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| GB0501999D0 (en) | 2005-02-01 | 2005-03-09 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| US8343953B2 (en) | 2005-06-22 | 2013-01-01 | Astex Therapeutics Limited | Pharmaceutical compounds |
| JP5066446B2 (ja) * | 2005-08-01 | 2012-11-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 血管新生阻害物質の効果を予測する方法 |
| TW200825054A (en) * | 2006-10-18 | 2008-06-16 | Wyeth Corp | Quinoline compounds |
| ES2470341T3 (es) * | 2007-04-05 | 2014-06-23 | Amgen, Inc | Moduladores de la aurora cinasa y método de uso |
| UA99284C2 (ru) | 2007-05-11 | 2012-08-10 | Елі Ліллі Енд Компані | ИНГИБИТОРЫ р70 S6-КИНАЗЫ |
| US7829574B2 (en) * | 2008-05-09 | 2010-11-09 | Hutchison Medipharma Enterprises Limited | Substituted quinazoline compounds and their use in treating angiogenesis-related diseases |
-
2010
- 2010-02-04 KR KR1020117021335A patent/KR101699991B1/ko active Active
- 2010-02-04 US US13/148,903 patent/US8637532B2/en active Active
- 2010-02-04 AU AU2010214095A patent/AU2010214095B2/en active Active
- 2010-02-04 EA EA201101182A patent/EA020731B1/ru not_active IP Right Cessation
- 2010-02-04 DK DK10705453.8T patent/DK2396307T3/en active
- 2010-02-04 MY MYPI2011003710A patent/MY160468A/en unknown
- 2010-02-04 HR HRP20141239AT patent/HRP20141239T1/hr unknown
- 2010-02-04 NZ NZ595087A patent/NZ595087A/xx unknown
- 2010-02-04 CA CA2751886A patent/CA2751886C/en active Active
- 2010-02-04 BR BRPI1008325-1A patent/BRPI1008325A2/pt not_active IP Right Cessation
- 2010-02-04 WO PCT/US2010/000313 patent/WO2010093419A1/en not_active Ceased
- 2010-02-04 SI SI201030849T patent/SI2396307T1/sl unknown
- 2010-02-04 JP JP2011550122A patent/JP5642714B2/ja active Active
- 2010-02-04 CN CN201080007165.1A patent/CN102317269B/zh active Active
- 2010-02-04 PT PT107054538T patent/PT2396307E/pt unknown
- 2010-02-04 PL PL10705453T patent/PL2396307T3/pl unknown
- 2010-02-04 EP EP10705453.8A patent/EP2396307B1/en active Active
- 2010-02-04 SG SG2011055001A patent/SG173473A1/en unknown
- 2010-02-04 UA UAA201110411A patent/UA107188C2/ru unknown
- 2010-02-04 ES ES10705453.8T patent/ES2527940T3/es active Active
- 2010-02-04 MX MX2011008395A patent/MX338354B/es active IP Right Grant
- 2010-02-11 AR ARP100100376A patent/AR075396A1/es not_active Application Discontinuation
-
2011
- 2011-08-02 IL IL214412A patent/IL214412A0/en active IP Right Grant
- 2011-08-11 CL CL2011001967A patent/CL2011001967A1/es unknown
- 2011-09-09 ZA ZA2011/06624A patent/ZA201106624B/en unknown
-
2013
- 2013-12-13 US US14/105,974 patent/US9040560B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532668A5 (cg-RX-API-DMAC10.html) | ||
| HRP20151260T1 (hr) | Supstituirani nikotinamidi kao modulatori kcnq2/3 | |
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| JP2007519754A5 (cg-RX-API-DMAC10.html) | ||
| JP2017511794A5 (cg-RX-API-DMAC10.html) | ||
| JP2015509543A5 (cg-RX-API-DMAC10.html) | ||
| JP2009541486A (ja) | プロリルヒドロキシラーゼ阻害剤および使用方法 | |
| JPWO2005012221A1 (ja) | ジフェニルエーテル化合物、その製造方法および用途 | |
| CN105473145A (zh) | 用于加速斑块消退的组合物和治疗方法 | |
| JP2011529037A5 (cg-RX-API-DMAC10.html) | ||
| JP2009503107A5 (cg-RX-API-DMAC10.html) | ||
| JP2014520809A5 (cg-RX-API-DMAC10.html) | ||
| RU2015143675A (ru) | Ship1 модуляторы и относящиеся к ним способы | |
| JP2016516028A5 (cg-RX-API-DMAC10.html) | ||
| JP2011511845A5 (cg-RX-API-DMAC10.html) | ||
| NZ612544A (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| RU2010139571A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола в качестве агонистов b2-адренергического рецептора | |
| RU2011149635A (ru) | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина | |
| JP2013509376A5 (cg-RX-API-DMAC10.html) | ||
| JP2009518421A5 (cg-RX-API-DMAC10.html) | ||
| RU2014132564A (ru) | Хитозан, ковалентно связанный с низкомолекулярным антагонистом интегрина, для нацеленной доставки | |
| RU2008127253A (ru) | 1,1,3-триоксо-1,2,5-тиадиазолидины и их применение в качестве ингибиторов птфаз | |
| JP2024510939A5 (cg-RX-API-DMAC10.html) | ||
| IL256646A (en) | Azaquinazoline carboxamide derivatives, their preparation and pharmaceutical compositions containing them | |
| RU2008143703A (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРОВ c-Src В КОМБИНАЦИИ С ПИРИМИДИЛАМИНОБЕНЗАМИДОМ ДЛЯ ЛЕЧЕНИЯ ЛЕЙКОЗА |